271 related articles for article (PubMed ID: 22678151)
1. The safety of peanut oral immunotherapy in peanut-allergic subjects in a single-center trial.
Yu GP; Weldon B; Neale-May S; Nadeau KC
Int Arch Allergy Immunol; 2012; 159(2):179-82. PubMed ID: 22678151
[TBL] [Abstract][Full Text] [Related]
2. Allergen-specific oral immunotherapy for peanut allergy.
Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
[TBL] [Abstract][Full Text] [Related]
3. First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy.
Soller L; Abrams EM; Carr S; Kapur S; Rex GA; Leo S; Lidman PG; Yeung J; Vander Leek TK; McHenry M; Wong T; Cook VE; Hildebrand KJ; Gerstner TV; Mak R; Lee NJ; Cameron SB; Chan ES
J Allergy Clin Immunol Pract; 2019; 7(8):2759-2767.e5. PubMed ID: 31002957
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.
Narisety SD; Frischmeyer-Guerrerio PA; Keet CA; Gorelik M; Schroeder J; Hamilton RG; Wood RA
J Allergy Clin Immunol; 2015 May; 135(5):1275-82.e1-6. PubMed ID: 25528358
[TBL] [Abstract][Full Text] [Related]
5. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
Loke P; Orsini F; Lozinsky AC; Gold M; O'Sullivan MD; Quinn P; Lloyd M; Ashley SE; Pitkin S; Axelrad C; Metcalfe JR; Su EL; Tey D; Robinson MN; Allen KJ; Prescott SL; Galvin AD; Tang MLK;
Lancet Child Adolesc Health; 2022 Mar; 6(3):171-184. PubMed ID: 35123664
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of desensitizing children highly allergic to peanut by high-dose oral immunotherapy.
Reier-Nilsen T; Michelsen MM; Lødrup Carlsen KC; Carlsen KH; Mowinckel P; Nygaard UC; Namork E; Borres MP; Håland G
Allergy; 2019 Feb; 74(2):337-348. PubMed ID: 30225844
[TBL] [Abstract][Full Text] [Related]
7. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.
Chinthrajah RS; Purington N; Andorf S; Long A; O'Laughlin KL; Lyu SC; Manohar M; Boyd SD; Tibshirani R; Maecker H; Plaut M; Mukai K; Tsai M; Desai M; Galli SJ; Nadeau KC
Lancet; 2019 Oct; 394(10207):1437-1449. PubMed ID: 31522849
[TBL] [Abstract][Full Text] [Related]
8. Safety of a peanut oral immunotherapy protocol in children with peanut allergy.
Hofmann AM; Scurlock AM; Jones SM; Palmer KP; Lokhnygina Y; Steele PH; Kamilaris J; Burks AW
J Allergy Clin Immunol; 2009 Aug; 124(2):286-91, 291.e1-6. PubMed ID: 19477496
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and immune regulation with peanut oral immunotherapy.
Jones SM; Pons L; Roberts JL; Scurlock AM; Perry TT; Kulis M; Shreffler WG; Steele P; Henry KA; Adair M; Francis JM; Durham S; Vickery BP; Zhong X; Burks AW
J Allergy Clin Immunol; 2009 Aug; 124(2):292-300, 300.e1-97. PubMed ID: 19577283
[TBL] [Abstract][Full Text] [Related]
10. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
[TBL] [Abstract][Full Text] [Related]
11. Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy.
Hourihane JO; Allen KJ; Shreffler WG; Dunngalvin G; Nordlee JA; Zurzolo GA; Dunngalvin A; Gurrin LC; Baumert JL; Taylor SL
J Allergy Clin Immunol; 2017 May; 139(5):1583-1590. PubMed ID: 28238744
[TBL] [Abstract][Full Text] [Related]
12. Administration of a probiotic with peanut oral immunotherapy: A randomized trial.
Tang ML; Ponsonby AL; Orsini F; Tey D; Robinson M; Su EL; Licciardi P; Burks W; Donath S
J Allergy Clin Immunol; 2015 Mar; 135(3):737-44.e8. PubMed ID: 25592987
[TBL] [Abstract][Full Text] [Related]
13. Peanut allergy and oral immunotherapy.
Lee TH; Chan JKC; Lau PC; Luk WP; Fung LH
Hong Kong Med J; 2019 Jun; 25(3):228-234. PubMed ID: 31178442
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome.
Anagnostou K; Clark A; King Y; Islam S; Deighton J; Ewan P
Clin Exp Allergy; 2011 Sep; 41(9):1273-81. PubMed ID: 21414048
[TBL] [Abstract][Full Text] [Related]
15. Peanut gastrointestinal delivery oral immunotherapy in adolescents: Results of the build-up phase of a randomized, double-blind, placebo-controlled trial (PITA study).
Fauquert JL; Michaud E; Pereira B; Bernard L; Gourdon-Dubois N; Rouzaire PO; Rochette E; Merlin E; Evrard B;
Clin Exp Allergy; 2018 Jul; 48(7):862-874. PubMed ID: 29665158
[TBL] [Abstract][Full Text] [Related]
16. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
Vickery BP; Scurlock AM; Kulis M; Steele PH; Kamilaris J; Berglund JP; Burk C; Hiegel A; Carlisle S; Christie L; Perry TT; Pesek RD; Sheikh S; Virkud Y; Smith PB; Shamji MH; Durham SR; Jones SM; Burks AW
J Allergy Clin Immunol; 2014 Feb; 133(2):468-75. PubMed ID: 24361082
[TBL] [Abstract][Full Text] [Related]
17. Peanut oral immunotherapy using an extensively heated and baked novel composition of peanuts.
Kidon MI; Shavit R; Levy Y; Haj Yahia S; Machnes-Maayan D; Frizinsky S; Maoz-Segal R; Offenganden I; Kenett RS; Nancy AL; Hovav R
Pediatr Allergy Immunol; 2024 May; 35(5):e14146. PubMed ID: 38783409
[TBL] [Abstract][Full Text] [Related]
18. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.
Nagakura KI; Yanagida N; Sato S; Nishino M; Asaumi T; Ogura K; Ebisawa M
Pediatr Allergy Immunol; 2018 Aug; 29(5):512-518. PubMed ID: 29603410
[TBL] [Abstract][Full Text] [Related]
19. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.
Patil SU; Steinbrecher J; Calatroni A; Smith N; Ma A; Ruiter B; Virkud Y; Schneider M; Shreffler WG
J Allergy Clin Immunol; 2019 Nov; 144(5):1310-1319.e4. PubMed ID: 31377342
[TBL] [Abstract][Full Text] [Related]
20. Oral immunotherapy using boiled peanuts for treating peanut allergy: An open-label, single-arm trial.
Grzeskowiak LE; Tao B; Aliakbari K; Chegeni N; Morris S; Chataway T
Clin Exp Allergy; 2023 Mar; 53(3):327-336. PubMed ID: 36628520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
